Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venrock
Biotech
CellCentric raises $220M to advance myeloma drug
In the last three years, CellCentric CEO Will West has been on a journey that has transformed how he thinks about the future of his company.
Will Maddox
May 6, 2026 7:00am
Candid scores Nasdaq listing via reverse merger Rallybio
Mar 2, 2026 11:45am
Angitia raises $130M to advance bone-building bispecifics
Feb 5, 2026 10:17am
Tubulis touts $361M series C as next-gen ADC data drop nears
Oct 15, 2025 5:01am
AIRNA preps for clinical test with $155M series B
Apr 1, 2025 7:00am
ADC biotech adds on $135M series B
Nov 25, 2024 7:00am
